Illumina Gets NIAID Grant for Proteomic Arrays | GenomeWeb

NEW YORK, Aug 12 (GenomeWeb News) - Illumina announced today that it has received a $1.2 million Phase 2 Small Business Innovative Research grant from the National Institute of Allergy and Infectious Diseases to support development of the firm's proteomic arrays.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.